GlassScriptPrepare for your visit
Sergei V Chekov
Internal Medicine · Philadelphia, PA · NPI 1265470306
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$9,844.76
in general payments reported to CMS, 2019-2025 · $1,424 in 2025
The $1,424 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Who reported paying
General payments only, top 6 by amount.
- Biohaven Pharmaceuticals, INC. $1,332.07
- Abbvie INC. $1,053.92
- Salix Pharmaceuticals, A Division of Bausch Health US, LLC $566.72
- Pfizer INC. $554.19
- Novo Nordisk INC $521.68
- Aimmune Therapeutics, INC. $461.20
Drugs and devices associated with these payments
Zenpep Linzess Creon Nurtec Odt Gemtesa Eliquis Rexulti Relistor Zavzpret Ozempic Paxlovid Repatha
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Sergei Chekov listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/103270/sergei-v-chekov